
Financial Toxicity: The Impact of a Cancer Diagnosis from there and beyond
-
Register
- User - $27.50
This is a 1 hour discussion regarding the extreme financial burden and toxicity on the cancer patient. What resources are available and how to use for the patient in need.
*Due to rapidly changing clinical knowledge, once purchased, you have 90 days access to complete this education.
Credits: 1.0 Contact Hours; 0.25 are Pharmacology
This activity is designated for 1 AAPA Category 1 CME credits. Approval is valid from 3/12/2025 to 3/11/2026 . PAs should only claim credit commensurate with the extent of their participation.
Expiration Date: March 11, 2026
$27.50
LEARNING OBJECTIVES
After taking part in this educational activity, participants should be better able to:
-Gain an understanding of financial toxicity and the impact on an individual diagnosed with cancer
-Identify the direct and indirect costs an individual diagnosed with cancer may face
-Distinguish between the different roles addressing financial toxicity
Aimee Hoch
MSW, LSW, OSW-C, FACCC
Aimee Hoch, LSW, OSW-C, FACCC, is a Masters Level Social Worker with 20 plus years of experience in both healthcare and behavioral health. Her practice is focused in oncology specifically addressing financial toxicity. Aimee earned her MSW from Fordham University Lincoln Center and is a licensed social worker. She is a Certified Oncology Social Worker.
Aimee is a Financial Navigator for the Cancer Program at Grand View Health where she created and implemented the Financial Navigation program in 2018. She is a consultant for the Cancer Support Community Helpline as a Financial Navigation Specialist. Aimee is an active member of
the Association of Cancer Care Center’s (ACCC) Financial Advocacy Network Advisory Committee, Initiatives Task Force, and has been recognized as a Fellow for the organization.
She is a member of the Medical Advisory Board at Living Beyond Breast Cancer. Aimee is a member of the Pennsylvania Cancer Coalition and their quality of life and survivorship workgroup. She is also a member of AOSW and AONN+. Aimee was selected for the CancerX Moonshot 2024 Mentor cohort. She speaks about financial toxicity and the role of financial navigation in cancer care.
CE/CME INFORMATION
Obtain Your Credits
To earn credits for this activity, navigate to the Content(s) tab and complete all course components in the following order: 1) watch the course presentation video; 2) complete the course evaluation; 3) pass the post-test with a score of 2/3 (66.7%) or higher. You may retake the post-test until a passing score is achieved, at which point you will be able to view/print a copy of your certificate of completion. This online certificate will also be saved within your profile 'My Courses/Certificates' -> 'Transcript/Certificates Earned' for future access.
Designation Statement
NPACE designates this educational activity for a maximum of 1.0 contact hours, of which 0.25 is pharmacology credit. Participants should claim only credit commensurate with the extent of their participation in the activity.
This activity is designated for 1 AAPA Category 1 CME credits. Approval is valid from 3/12/2025 to 3/11/2026 .
Accreditation Statement
Nurse Practitioner Associates for Continuing Education is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
In addition to ANCC, NPACE is approved as a provider of continuing education in nursing by: the California Board of Registered Nursing, Provider Number CEP8720
This activity has been reviewed by the American Academy of Physician Associates Review Panel and is compliant with AAPA CME Criteria. This activity is designated for 1 AAPA Category 1 CME credits. Approval is valid from 3/12/2025 to 3/11/2026 . PAs should only claim credit commensurate with the extent of their participation.
DISCLOSURES
Faculty
Contributing faculty, Aimee Hoch, MSW, LSW, OSW-C, FACCC has disclosed no financial relationships.
Planners
All planners and contributors involved in this educational activity have disclosed no relevant financial relationships.
Disclaimer
The material presented in this continuing education program is being made available for educational purposes only and is not intended to represent the best or only methods, medications and/or guidelines appropriate for the medical situation discussed. Rather the material is intended to present an approach, view, statement, or opinion of the presenter(s), which may be helpful, or of interest to other practitioners and should not be used by clinicians without the evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. NPACE disclaims any liability, loss, injury, or damage incurred as a consequence, directly or indirectly, of the use and application of any information given in a presentation.
Disclosure of Unlabeled Use
This educational activity may mention the uses of products that are not approved by the FDA for the indication(s) being discussed. The presenter(s) are instructed to notify participants when they are discussing unapproved uses or investigational agents. The opinions related to unapproved uses of products are solely those of the presenter(s) and are not endorsed or recommended by NPACE. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Commercial Support
There is no commercial support for this activity.
Key:




